Stanford University
Showing 8,771-8,780 of 35,007 Results
-
Katherine Ferrara
Professor of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly InterestsMy focus is image-guided drug and gene delivery and I am engaged in the design of imaging devices, molecularly-targeted imaging probes and engineered delivery vehicles, drawing upon my education in biology and imaging physics and more than 20 years of experience with the synthesis and labeling of therapeutic particles. My laboratory has unique resources for and substantial experience in synthetic chemistry and ultrasound, CT, MR and PET imaging.
-
Lorenzo Ferrari
Postdoctoral Scholar, Cardiothoracic Surgery
BioLorenzo Ferrari, PhD, is a biomedical engineer interested in cardiovascular flows and in developing benchtop systems for in vitro evaluation of cardiac devices. His current postdoctoral research in the Department of Cardiothoracic Surgery at Stanford University focuses on simulating and testing transcatheter valves implanted in the right ventricular outflow tract using 4D Flow MRI, working with Doff B. McElhinney, Daniel B. Ennis, and Alison L. Marsden. He obtained his PhD summa cum laude in Biomedical Engineering from the University of Bern, where he investigated the influence of heart valve design and size under different hemodynamic conditions using particle velocimetry techniques. During his PhD, he completed a secondment at the University of Twente in the Physics of Fluids group at the Max Planck Center for Complex Fluid Dynamics, collaborating with Michel Versluis and Guillaume Lajoinie to assess the stability of flow fields past valve prostheses.
-
Sofia Ferreira
Postdoctoral Scholar, Radiation Biology
BioCancer Biology Scientist focused on improving treatment options on refractory tumors, primarily pancreatic cancer. My research focuses on uncovering innovative strategies to enhance the responsiveness of pancreatic cancer to existing treatments through fundamental research and preclinical approaches:
1.Investigate key molecular pathways in pancreatic cancer using in vivo, organelle-specific omics to identify new therapeutic targets
2.Identify unique drivers and tumor-stroma crosstalk across distinct pancreatic cancer subtypes
3.Exploit tumor cell innate immunity pathways to enhance pancreatic cancer responses to immunotherapy
